Klein G
Natl Cancer Inst Monogr. 1976 Nov;44:135-6.
The escape from immune rejection is, like the development of drug resistance in microorganisms, a multi-pathway process. Selection favors the phenotype, i.e., the cell that can grow in spite of the immune rejection process, not the underlying mechanism. Experimental evidence documents the roles of host immunosuppression (genetic or environmental), immunoresistance at the cellular level, "sneaking through" (i.e., growth of a tumor to irreversible size prior to the mobilization of an appropriate immune response), lack of antigenic recognition, and blocking enhancement type reactions.
免疫逃逸如同微生物耐药性的产生一样,是一个多途径过程。选择有利于表型,即尽管存在免疫排斥过程仍能生长的细胞,而非潜在机制。实验证据证明了宿主免疫抑制(遗传或环境因素)、细胞水平的免疫抗性、“潜行通过”(即肿瘤在引发适当免疫反应之前生长到不可逆转的大小)、缺乏抗原识别以及阻断增强型反应的作用。